Float Short %

4.99

Margin Of Safety %

-22

Put/Call OI Ratio

0.36

EPS Next Q Diff

-0.23

EPS Last/This Y

12.4

EPS This/Next Y

0.3

Price

150.13

Target Price

130.56

Analyst Recom

2.57

Performance Q

55.3

Relative Volume

1.37

Beta

1.46

Ticker: ILMN

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-12-09	ILMN	132.11	0.21	0.41	79840
2025-12-10	ILMN	134.94	0.22	0.30	80278
2025-12-11	ILMN	136.47	0.22	1.06	80323
2025-12-12	ILMN	134.9	0.22	0.16	80527
2025-12-15	ILMN	134.92	0.22	1.41	80710
2025-12-16	ILMN	131.15	0.23	0.16	80936
2025-12-17	ILMN	129.56	0.23	0.02	81051
2025-12-18	ILMN	130.55	0.23	0.47	80397
2025-12-19	ILMN	134.51	0.24	0.28	80960
2025-12-22	ILMN	137.67	0.31	0.35	46964
2025-12-23	ILMN	136.22	0.31	0.59	47246
2025-12-26	ILMN	134.97	0.31	0.26	47502
2025-12-29	ILMN	134.49	0.32	0.84	48216
2025-12-30	ILMN	132.77	0.32	0.80	48230
2025-12-31	ILMN	131.14	0.32	0.46	48293
2026-01-02	ILMN	134.38	0.32	0.19	48373
2026-01-05	ILMN	141.37	0.32	1.40	48655
2026-01-06	ILMN	147.27	0.34	0.74	49570
2026-01-07	ILMN	150.17	0.36	0.33	50119
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-12-09	ILMN	132.13	42.5	88.3	4.71
2025-12-10	ILMN	132.13	42.5	71.4	4.71
2025-12-11	ILMN	136.44	42.5	61.9	4.71
2025-12-12	ILMN	134.85	42.5	39.2	4.71
2025-12-15	ILMN	134.92	42.5	51.0	4.71
2025-12-16	ILMN	134.92	42.5	25.9	4.71
2025-12-17	ILMN	129.56	42.5	35.7	4.71
2025-12-18	ILMN	130.48	42.5	57.6	4.71
2025-12-19	ILMN	134.82	42.5	83.1	4.71
2025-12-22	ILMN	137.82	42.5	72.7	4.71
2025-12-23	ILMN	135.99	42.5	38.4	4.71
2025-12-26	ILMN	135.00	42.5	48.3	4.71
2025-12-29	ILMN	134.54	42.5	47.7	4.71
2025-12-30	ILMN	132.81	42.5	38.4	4.71
2025-12-31	ILMN	131.16	42.5	38.9	4.71
2026-01-02	ILMN	134.38	42.5	74.8	4.71
2026-01-05	ILMN	141.36	42.5	102.0	4.71
2026-01-06	ILMN	147.08	42.2	90.8	4.71
2026-01-07	ILMN	150.13	42.2	71.0	4.71
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-12-09	ILMN	-0.00	0.73	4.41
2025-12-10	ILMN	-0.00	0.73	4.75
2025-12-11	ILMN	-0.00	0.73	4.75
2025-12-12	ILMN	-0.00	0.73	4.75
2025-12-15	ILMN	-0.00	0.73	4.75
2025-12-16	ILMN	-0.01	0.73	4.75
2025-12-17	ILMN	-0.01	0.73	4.75
2025-12-18	ILMN	-0.01	0.73	4.75
2025-12-19	ILMN	-0.01	0.73	4.75
2025-12-22	ILMN	-0.01	0.71	4.75
2025-12-23	ILMN	-0.01	0.71	4.75
2025-12-26	ILMN	-0.01	0.71	4.99
2025-12-29	ILMN	-0.01	0.70	4.99
2025-12-30	ILMN	-0.01	0.70	4.99
2025-12-31	ILMN	-0.01	0.70	4.99
2026-01-02	ILMN	-0.01	0.70	4.99
2026-01-05	ILMN	-0.01	0.71	4.99
2026-01-06	ILMN	-0.01	0.71	4.99
2026-01-07	ILMN	-0.01	0.71	4.99
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

1.34

Avg. EPS Est. Current Quarter

1.23

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

-0.01

Institutional Transactions

0.71

Beta

1.46

Average Sales Estimate Current Quarter

1102

Average Sales Estimate Next Quarter

1056

Fair Value

117.19

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

72.2

Max Drawdown 5-Year %

-86.2

Target Price

130.56

P/E

33.64

Forward P/E

29.68

PEG

2.54

P/S

5.35

P/B

9.65

P/Free Cash Flow

22.94

EPS

4.46

Average EPS Est. Cur. Y

4.71

EPS Next Y. (Est.)

5.01

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.41

Relative Volume

1.37

Return on Equity vs Sector %

2.4

Return on Equity vs Industry %

18.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Illumina, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 8970

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.

stock quote shares ILMN – Illumina, Inc. Stock Price stock today

news today ILMN – Illumina, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ILMN – Illumina, Inc. yahoo finance google finance

stock history ILMN – Illumina, Inc. invest stock market

stock prices ILMN premarket after hours

ticker ILMN fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ILMN

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y